| 今开：0.0 | 昨收：15.25 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.53615457E8 |
乔纳森牛2015-04-24 05:34
$AERIE PHARMACEUTICALS INC(AERI)$ 盘后该公司宣布其主打产品治疗青光眼组合降低眼内压的药物疗法临床3期 Phase 3 registration trial (Rocket 1) for RhopressaTM,没有达到预期结果。公司主席Vicente Anido, Jr.对此结果表示失望。公司管理层并在今天下午5点召开投资者会议解答。这家公司记得是...查看全文
割资本主义羊毛2015-04-24 04:59
$INOTEK PHARMACEUTICALS CORP(ITEK)$ 盘后得益于竞争对手$AERIE PHARMACEUTICALS INC(AERI)$ 的三期失败。查看全文
疑夕2015-03-24 20:08
$AERIE PHARMACEUTICALS INC(AERI)$ 完成Rhopressa降低眼内压的第二项III期临床试验（Rocket 2），第一项III期临床试验（Rocket 1）的结果将在mid-Q2（5月？）公布。查看全文
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058186 Size: 10 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058188 Size: 8 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058189 Size: 12 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058191 Size: 10 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058183 Size: 8 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058176 Size: 12 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058180 Size: 8 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058172 Size: 10 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058165 Size: 12 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058154 Size: 10 KB 网页链接